Intralinks Studyspace™

Safety Document Distribution

Intralinks Studyspace expedites safety document – SUSAR – distribution through its secure online portal designed for real-time safety reporting to your clinical sites. 

Communication-focused clinical trial management

Intralinks Studyspace enables investigators to submit, exchange, and react to SUSAR clinical site reports in real time. Through intuitive collaboration tools and tracking and status reports, Intralinks Studyspace does more than improve workflows — Intralinks Studyspace increases the efficacy of the entire clinical trial process.   

  • Allows sponsors to submit confidential serious adverse event (SAE) reports to site investigators in real time
  • Instantaneously disseminates suspected unexpected serious adverse reactions (SUSARs) throughout the investigative sites, institutional review boards, ethics committees, and participating research organizations
  • Enables investigators to quickly act accordingly to reduce additional risk
  • Ensures compliance to the reporting timelines

Because sponsors can inform investigators of the events as they unfold, crucial information may be effectively spread throughout all participating sites. Sponsors no longer have to distribute safety packages via overnight mail — saving an average of $36,000 per study and reducing labor hours devoted to manual site management processes by 80%.

For example: Studyspace can help automate end-to-end site feasibility processes, providing sponsors with detailed insights and enabling better site selection. Optimal sites produce more effective trials that are on time and on budget.

Watch the Demo

Click here for the replay of the 24th October 2013 Webcast: Informing the Investigator - Implementing an Automated SUSAR Reporting System

Intralinks Studyspace

Accelerate breakthroughs. Deliver drugs and therapies to market faster when you manage clinical trials in a secure online repository built upon communication and effective, real-time information exchange.

Contact us to learn more: